In some situations, Treg defects can be reversed by successful treatment of autoimmune disease, particularly RA, by neutralization of cytokines (such as TNF or IL-6) that can impair Treg differentiation and/or functional effectiveness [22], but similar studies have not been reported in SSc. Here, TNF is linked to systemic sclerosis.